SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form SC 13G/A - Statement of Beneficial Ownership by Certain Investors: [Amend]
SEC Accession No. 0001193125-17-263636
Filing Date
2017-08-21
Accepted
2017-08-21 15:51:33
Documents
3
Group Members
JEANI DELAGARDELLELIAM RATCLIFFENEW LEAF VENTURE ASSOCIATES II, L.P.NEW LEAF VENTURE MANAGEMENT II, L.L.C.RONALD HUNTVIJAY LATHI

Document Format Files

Seq Description Document Type Size
1 SC 13G/A d422922dsc13ga.htm SC 13G/A 29129
2 EX-99.1 d422922dex991.htm EX-99.1 12022
3 EX-99.2 d422922dex992.htm EX-99.2 10074
  Complete submission text file 0001193125-17-263636.txt   53043
Mailing Address TIMES SQUARE TOWER 7 TIMES SQUARE, SUITE 3502 NEW YORK NY 10036
Business Address TIMES SQUARE TOWER 7 TIMES SQUARE, SUITE 3502 NEW YORK NY 10036 (646) 871-6400
New Leaf Ventures II, L.P. (Filed by) CIK: 0001441439 (see all company filings)

IRS No.: 320214549 | State of Incorp.: DE | Fiscal Year End: 1231
Type: SC 13G/A

Mailing Address 94C INNOVATION DRIVE MILTON PARK ABINGDON X0 OX14 4RZ
Business Address 94C INNOVATION DRIVE MILTON PARK ABINGDON X0 OX14 4RZ 44 01235 442780
Oxford Immunotec Global PLC (Subject) CIK: 0001586049 (see all company filings)

IRS No.: 000000000 | State of Incorp.: X0 | Fiscal Year End: 1231
Type: SC 13G/A | Act: 34 | File No.: 005-87926 | Film No.: 171043112
SIC: 2835 In Vitro & In Vivo Diagnostic Substances